Literature DB >> 25431745

Strategies for Management of Synchronous Colorectal Metastases.

Jason A Castellanos1, Nipun B Merchant1.   

Abstract

The management of synchronous presentation of colorectal cancer and liver metastases has long been a topic of debate and discussion for surgeons due to the unique dilemma of balancing operative timing along with treatment strategy. Operative strategies for resection include staged resection with colon first approach, "reverse" staged resection with liver metastases resected first, and one-stage, or simultaneous, resection of both the primary tumor and liver metastases approach. These operative strategies can be further augmented with perioperative chemotherapy and other novel approaches that may improve resectability and patient survival. The decision on operative timing and approach, however, remains largely dependent on the surgeon's determination of disease resectability, patient fitness, and the need for neoadjuvant chemotherapy.

Entities:  

Keywords:  CRC; Chemoradiation; Chemotherapy; Colorectal cancer; Hepatectomy; Lymphadenopathy; Metastases; Synchronous liver metastasis; sCRLM

Year:  2014        PMID: 25431745      PMCID: PMC4244297          DOI: 10.1007/s40137-014-0062-1

Source DB:  PubMed          Journal:  Curr Surg Rep        ISSN: 2167-4817


  65 in total

1.  Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study.

Authors:  Daniel Jaeck; Hiroshi Nakano; Philippe Bachellier; Keiichiro Inoue; Jean-Christophe Weber; Elie Oussoultzoglou; Philippe Wolf; Marie-Pierre Chenard-Neu
Journal:  Ann Surg Oncol       Date:  2002-06       Impact factor: 5.344

2.  Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Murielle Mauer; Erik Tanis; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2013-10-11       Impact factor: 41.316

3.  Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma.

Authors:  T Shibata; T Niinobu; N Ogata; M Takami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

4.  Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.

Authors:  M Margaret Kemeny; Sudeshna Adak; Bruce Gray; John S Macdonald; Thomas Smith; Stuart Lipsitz; Elin R Sigurdson; Peter J O'Dwyer; Al B Benson
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

5.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Robbert J de Haas; Dennis A Wicherts; Thomas A Aloia; Valérie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

Review 6.  Defining the optimal therapy sequence in synchronous resectable liver metastases from colorectal cancer: a decision analysis approach.

Authors:  E Van Dessel; K Fierens; P Pattyn; Y Van Nieuwenhove; F Berrevoet; R Troisi; W Ceelen
Journal:  Acta Chir Belg       Date:  2009 May-Jun       Impact factor: 1.090

7.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

8.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

9.  Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases.

Authors:  A E van der Pool; J H de Wilt; Z S Lalmahomed; A M Eggermont; J N Ijzermans; C Verhoef
Journal:  Br J Surg       Date:  2010-03       Impact factor: 6.939

10.  Evidence for a synchronous operative approach in the treatment of colorectal cancer with hepatic metastases: a case matched study.

Authors:  S J Moug; D Smith; E Leen; C Roxburgh; P G Horgan
Journal:  Eur J Surg Oncol       Date:  2010-01-19       Impact factor: 4.424

View more
  5 in total

1.  Role of a liver-first approach for synchronous colorectal liver metastases.

Authors:  Kun Wang; Wei Liu; Xiao-Luan Yan; Bao-Cai Xing
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 2.  A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer.

Authors:  Fotios Loupakis; Alexander Stein; Marc Ychou; Frank Hermann; Antonieta Salud; Pia Österlund
Journal:  Target Oncol       Date:  2016-06       Impact factor: 4.493

3.  Robotic simultaneous resection of rectal cancer and liver metastases.

Authors:  Supreet Sunil; Juliana Restrepo; Arash Azin; Dhruvin Hirpara; Sean Cleary; Michelle C Cleghorn; Alice Wei; Fayez A Quereshy
Journal:  Clin Case Rep       Date:  2017-10-05

Review 4.  Simultaneous Minimally Invasive Treatment of Colorectal Neoplasm with Synchronous Liver Metastasis.

Authors:  Stefano Garritano; Federico Selvaggi; Marcello Giuseppe Spampinato
Journal:  Biomed Res Int       Date:  2016-05-15       Impact factor: 3.411

5.  Chemotherapy for breast cancer progresses to liver metastases after surgery and systemic treatment.

Authors:  Tao Yin; Lei Nie; Dongde Wu; Baozhen Liu; Yaojun Feng; Xinhong Wu; Chenggang Luo; Jianjun Liang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.